{"database": "lobbying", "table": "lobbying_activities", "rows": [[1733201, "c168b005-fb7f-423a-a485-eb74947e8340", "Q3", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2015, "third_quarter", "PHA", "H.R. 6 - 21st Century Cures- Issues related to opioid abuse, prescription medication exclusivity and biosimilars.\n\nIssues related to Senate Finance Committee activity on advances in chronic care with a focus on medication-based therapies.\n\nCCIIO issuer letter and regulations focused on bids for 2015 and impacts on access to prescription medications and pharmacy networks. \n\nWork focused on Medicare Part D and related regulations and reports specific to pharmacy networks. \n\nIssues related to the implementation of the health care law that impact public and private sector pharmacy benefits. \n\nCMS call letter focused on changes in policies regarding mail order and pharmacy networks. \n\nIssues related to pricing and access to prescription drugs including specialty drugs and biosimilars.\n\n\nIssues related to patents and the treatment of prescription medications.", "Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2015-10-16T10:19:23.057000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1733201"], "units": {}, "query_ms": 105.4845800390467, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}